Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRASTUZUMAB Cause Clostridium difficile infection? 107 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 107 reports of Clostridium difficile infection have been filed in association with TRASTUZUMAB (Trazimera). This represents 0.2% of all adverse event reports for TRASTUZUMAB.

107
Reports of Clostridium difficile infection with TRASTUZUMAB
0.2%
of all TRASTUZUMAB reports
17
Deaths
91
Hospitalizations

How Dangerous Is Clostridium difficile infection From TRASTUZUMAB?

Of the 107 reports, 17 (15.9%) resulted in death, 91 (85.0%) required hospitalization, and 16 (15.0%) were considered life-threatening.

Is Clostridium difficile infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB. However, 107 reports have been filed with the FAERS database.

What Other Side Effects Does TRASTUZUMAB Cause?

Diarrhoea (4,996) Off label use (3,802) Nausea (3,499) Fatigue (3,417) Myelosuppression (2,552) Disease progression (2,449) Death (2,378) Vomiting (2,244) Dyspnoea (2,010) Pyrexia (1,886)

What Other Drugs Cause Clostridium difficile infection?

ADALIMUMAB (1,502) INFLIXIMAB (1,419) VEDOLIZUMAB (1,130) LENALIDOMIDE (814) VANCOMYCIN (743) METRONIDAZOLE (619) PREDNISONE (618) METHOTREXATE (588) RITUXIMAB (532) CIPROFLOXACIN (508)

Which TRASTUZUMAB Alternatives Have Lower Clostridium difficile infection Risk?

TRASTUZUMAB vs TRASTUZUMAB-ANNS TRASTUZUMAB vs TRASTUZUMAB DERUXTECAN TRASTUZUMAB vs TRASTUZUMAB-DKST TRASTUZUMAB vs TRASTUZUMAB-DTTB TRASTUZUMAB vs TRASTUZUMAB EMTANSINE

Related Pages

TRASTUZUMAB Full Profile All Clostridium difficile infection Reports All Drugs Causing Clostridium difficile infection TRASTUZUMAB Demographics